INTRACEREBROVENTRICULARLY APPLIED PEPTIDASE INHIBITORS INCREASE ENDOGENOUS ANGIOTENSIN LEVELS
INTRACEREBROVENTRICULARLY APPLIED PEPTIDASE INHIBITORS INCREASE ENDOGENOUS ANGIOTENSIN LEVELS
复制标题
DOI:
10.1016/0006-8993(90)90819-w
复制
发表时间:
1990-10-08
期刊:
影响因子:
2.9
通讯作者:
WRIGHT, JW
中科院分区:
文献类型:
--
作者:
BATT, CM;JENSEN, LL;WRIGHT, JW
Rats received the aminopeptidase inhibitors amastatin (AM) and bestatin (BE), and carboxypeptidase inhibitor Plummer''s (PL) via intracerebroventricular infusion in various combinations, i.e. PL alone, AM+BE, and a cocktail consisting of AM+BE+PL. Blood pressure responses were recorded and a postinfusion sample of cerebrospinal fluid (CSF) was radioimmunoassayed for endogenous angiotensin levels. Results indicate that CSF angiotensin was increased approximately 1.5 .times. over control levels when PL was infused; a 2.5 .times. increase accompanied AM+BE administration; and a 10.3 .times. elevation was measured when all 3 inhibitors wee infused as a cocktail. Concomitant elevations in blood pressure accompanied increased concentations of angiotensin. We conclude that endogenous levels of angiotensin can be significantly increased in the ventricular space when a combination of these inhibitors is utilized to protect both the amino and carboxyl terminals of the angiotensin molecule from enzymatic degradation.